FY25 Results and Acquisition Announcement
| Stock | CCL.ASX (CCL.ASX) |
|---|---|
| Release Time | 22 Aug 2025, 8:39 a.m. |
| Price Sensitive | Yes |
Cuscal Exceeds FY25 NPAT Forecast, Acquires Indue
- FY25 Pro forma NPAT of $38.4 million ahead of Prospectus forecast
- Strategic acquisition of Indue to deliver material synergies and operating efficiencies
- Outlook maintained with low double-digit underlying NPAT growth
Cuscal Limited (ASX: CCL) has announced its financial results for the 12 months ended 30 June 2025, with FY25 Pro Forma NPAT exceeding the Prospectus forecast. Consolidated Profit attributable to the owners of Cuscal (Statutory NPAT) decreased by 9% to $28.7 million, impacted by non-recurring 'Offer costs' and other costs incurred as a result of its ASX listing. Cuscal's FY25 Result highlights include 8% transaction volume growth, 6% increase in Total Adjusted Net Operating Income to $290.4 million, 13% growth in Pro forma Adjusted EBITDA to $65.7 million, and a 17% increase in Pro forma NPAT to $38.4 million. Cuscal also announced the strategic acquisition of Indue Limited for $75 million in cash, which is expected to deliver $15-$20 million in annual run rate cost synergies and drive attractive EPS accretion of over 25% once fully realized. The combined business will benefit from enhanced product and service offerings, operational efficiencies, and improved resilience across capital, capabilities, cybersecurity, and fraud monitoring. Looking ahead, Cuscal remains focused on executing its strategy to deliver sustainable and profitable growth, with expectations of mid-to-high single digit transaction volume growth and low double-digit underlying NPAT growth.
Cuscal expects to deliver low double-digit underlying NPAT growth in the financial year ending 30 June 2025.
Cuscal remains focused on executing its strategy to deliver sustainable and profitable growth, with expectations of mid-to-high single digit transaction volume growth and low double-digit underlying NPAT growth.